258273-50-6 Usage
Uses
Used in Organic Synthesis:
Methyl 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate is used as a starting material in organic synthesis for the creation of a variety of complex organic molecules. Its unique structure allows for the development of new compounds with potential applications in various fields.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate is utilized as a precursor for the synthesis of pharmaceuticals. Its incorporation into drug molecules can potentially enhance their therapeutic properties, such as improving efficacy, selectivity, or bioavailability.
Used in Pharmaceutical Development:
Methyl 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate is used as a key intermediate in the development of new pharmaceuticals. Its specific properties and reactivity make it a valuable component in the design and synthesis of innovative drug candidates, which may address unmet medical needs or offer improved treatment options.
Used in Bioactive Compound Research:
Methyl 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate is also used in research aimed at discovering new bioactive compounds. Its unique structure may contribute to the development of molecules with novel biological activities, which could lead to the identification of new therapeutic agents or probes for biological studies.
The specific applications and uses of Methyl 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetate are continually being explored and expanded upon as research in organic synthesis and medicinal chemistry progresses. Its role in the development of new pharmaceuticals and bioactive compounds is subject to ongoing investigation and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 258273-50-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,8,2,7 and 3 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 258273-50:
(8*2)+(7*5)+(6*8)+(5*2)+(4*7)+(3*3)+(2*5)+(1*0)=156
156 % 10 = 6
So 258273-50-6 is a valid CAS Registry Number.
InChI:InChI=1/C18H18N2O2/c1-12-4-7-14(8-5-12)18-15(10-17(21)22-3)20-11-13(2)6-9-16(20)19-18/h4-9,11H,10H2,1-3H3
258273-50-6Relevant academic research and scientific papers
Preparation method of zolpidem
-
, (2020/05/05)
The invention belongs to the field of pharmacy, and relates to a method for preparing zolpidem. The preparation method comprises the following steps: taking maleic anhydride and 2-amino-4-methylpyridine as raw materials, and carrying out a series of react
Rhodium catalyzed direct C3-ethoxycarbonylmethylation of imidazo[1,2-a]pyridines with ethyl diazoacetate
Dong, Hui,Hu, Wenhao,Huang, Qiuyao,Li, Bingbing,Wang, Yuanxiang
supporting information, (2020/02/13)
An efficient and environment-friendly C3-ethoxycarbonylmethylation of imidazo[1,2-a]pyridines with ethyl diazoacetate in the presence of a Rh(II) catalyst was developed. Such strategy not only enables the synthesis of zolpidem, but also provides a way to
Practical and scalable preparation of Minodronic acid and Zolpidem from 2-chloroimidazole[1,2-a]pyridines
Wang, Yuheng,Zhang, Bingbing,Zheng, Yinying,Ma, Qiaoning,Sui, Qiang,Lei, Xinsheng
, p. 1064 - 1071 (2019/01/14)
Practical and scalable procedures for Minodronic acid and Zolpidem are developed with short reaction sequences from 2-aminopyridines and maleic anhydride, respectively. The new procedures avoid column chromatography for the purification in all synthetic steps. Key aspects of this development involve reductive hydrodechlorination and Suzuki coupling reaction of 2-chloroimidazole[1,2-a]pyridines, and their application towards synthesis of the two drugs is also addressed.
Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
-
Page/Page column 9-10, (2008/06/13)
The invention provides novel imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides of formula (I) wherein R1, R2 and R3 have different meanings, and pharmaceutically acceptable salts, polymorphs, hydrates, tautomers, solvates and stereoisomers thereof. Compou
